Laboratorios Farmacéuticos Rovi SA (41L)
FSX
Closed
Oct 2, 2026
Day's Range
57.4052 wk Range
53.10Overview - 41L - Laboratorios Farmacéuticos Rovi SA
Key Statistics
Valuation
Enterprise Value
3.03B
P/E (Trailing)
16.40
Price / Sales (TTM)
3.92
Price / Book
4.33
EV / EBITDA
17.24
Profitability
Gross Margin
68.67%
Profit Margin
23.95%
Operating Margin
9.41%
Return on Assets
9.44%
Return on Equity
28.65%
Ownership
Shares Outstanding
51.14M
Float
16.20M
Held by Insiders
68.19%
Held by Institutions
17.00%
Price stats
Beta
0.23
50-Day Avg
58.89
200-Day Avg
67.01
Dividends
Payout Ratio
25.83%
Frequency
Annual
Market Cap - 41L - Laboratorios Farmacéuticos Rovi SA
Peers - 41L - Laboratorios Farmacéuticos Rovi SA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- 41LFSXLaboratorios Farmacéuticos Rovi SA3.03BMarket Cap-2.47%52-week change16.41P/E (Trailing)23.95%Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)29.78%Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)16.96%Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)11.21%Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)11.21%Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)14.57%Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)24.93%Profit Margin
Profile Summary - 41L - Laboratorios Farmacéuticos Rovi SA
About
Laboratorios Farmacéuticos Rovi SA is a Spanish biotechnology and pharmaceutical company specializing in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. Founded in 1946, it operates through two primary segments: Manufacturing, focused on contract development and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
